Join Growin Stock Community!

Cryoport, inc.CYRX.US Overview

US StockIndustrials
(No presentation for CYRX)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

CYRX AI Insights

CYRX Overall Performance

CYRX AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

CYRX Recent Performance

-2.19%

Cryoport, inc.

0.28%

Avg of Sector

-0.31%

S&P500

CYRX PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

CYRX Key Information

CYRX Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

CYRX Profile

Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle. It also provides information dashboards and validation documentation for shipments through data collected by the SmartPak Condition Monitoring System; and vacuum insulated aluminum dewars and cryogenic freezers systems. In addition, the company offers biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; transportation of frozen biological specimens to and from customer locations; and management of incoming and outgoing biological specimens, as well as provides logistics support and management; and short-term logistics and engineering consulting services. It serves biopharma/pharma, animal health, and human reproductive medicine markets. The company was founded in 1999 and is headquartered in Brentwood, Tennessee.

Price of CYRX

CYRX FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

CYRX Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
1.35
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
1.73
PB Ratio
0.90
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
46.58%
Net Margin
35.52%
Revenue Growth (YoY)
-15.86%
Profit Growth (YoY)
-7.31%
3-Year Revenue Growth
-9.89%
3-Year Profit Growth
-6.89%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
1.35
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
1.73
PB Ratio
0.90
Price-to-FCF
-
Gross Margin
46.58%
Net Margin
35.52%
Revenue Growth (YoY)
-15.86%
Profit Growth (YoY)
-7.31%
3-Year Revenue Growth
-9.89%
3-Year Profit Growth
-6.89%

  • When is CYRX's latest earnings report released?

    The most recent financial report for Cryoport, inc. (CYRX) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating CYRX's short-term business performance and financial health. For the latest updates on CYRX's earnings releases, visit this page regularly.

  • What is the operating profit of CYRX?

    According to the latest financial report, Cryoport, inc. (CYRX) reported an Operating Profit of -9.93M with an Operating Margin of -22.45% this period, representing a growth of 39.53% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is CYRX's revenue growth?

    In the latest financial report, Cryoport, inc. (CYRX) announced revenue of 44.23M, with a Year-Over-Year growth rate of -21.94%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does CYRX have?

    As of the end of the reporting period, Cryoport, inc. (CYRX) had total debt of 230.86M, with a debt ratio of 0.3. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does CYRX have?

    At the end of the period, Cryoport, inc. (CYRX) held Total Cash and Cash Equivalents of 257.91M, accounting for 0.33 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does CYRX go with three margins increasing?

    In the latest report, Cryoport, inc. (CYRX) did not achieve the “three margins increasing” benchmark, with a gross margin of 48.2%%, operating margin of -22.45%%, and net margin of -20.2%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess CYRX's profit trajectory and future growth potential.

  • Is CYRX's EPS continuing to grow?

    According to the past four quarterly reports, Cryoport, inc. (CYRX)'s earnings per share (EPS) shows a declining trend, with the latest EPS at -0.18. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of CYRX?

    Cryoport, inc. (CYRX)'s Free Cash Flow (FCF) for the period is -1.85M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 58.65% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.